Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
ZNTL — Price & Forward EBITDA
Forward EBITDA (M)

Float Short %

8.57

Margin Of Safety %

Put/Call OI Ratio

0.12

EPS Next Q Diff

-0.07

EPS Last/This Y

0.21

EPS This/Next Y

Price

2.68

Target Price

5.31

Analyst Recom

2.11

Performance Q

94.89

Upside

-2,603.7%

Beta

1.54

Ticker: ZNTL



20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-03-09ZNTL2.480.120.005052
2026-03-10ZNTL3.060.110.005111
2026-03-11ZNTL2.970.080.066826
2026-03-12ZNTL2.760.080.007072
2026-03-13ZNTL2.750.080.007072
2026-03-17ZNTL2.740.080.007105
2026-03-18ZNTL2.520.081.837123
2026-03-19ZNTL2.570.085.007129
2026-03-20ZNTL2.610.090.007140
2026-03-23ZNTL2.550.0577.004553
2026-03-24ZNTL2.470.050.044545
2026-03-25ZNTL2.560.050.335270
2026-03-26ZNTL2.680.050.335270
2026-03-27ZNTL2.110.056.235290
2026-03-30ZNTL2.140.120.005736
2026-03-31ZNTL2.350.120.005771
2026-04-01ZNTL2.580.100.006761
2026-04-02ZNTL2.640.100.006761
2026-04-06ZNTL2.690.100.576765
2026-04-07ZNTL2.680.120.007197
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1



20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-03-09ZNTL2.485.9- -1.76
2026-03-10ZNTL3.065.9- -1.76
2026-03-11ZNTL2.965.9- -1.76
2026-03-12ZNTL2.755.9- -1.76
2026-03-13ZNTL2.725.9- -1.76
2026-03-17ZNTL2.745.9- -1.76
2026-03-18ZNTL2.525.9- -1.76
2026-03-19ZNTL2.575.9- -1.76
2026-03-20ZNTL2.610.4- -1.76
2026-03-23ZNTL2.540.4- -1.76
2026-03-24ZNTL2.470.4- -1.76
2026-03-25ZNTL2.560.4- -1.76
2026-03-26ZNTL2.680.4- -1.76
2026-03-27ZNTL2.110.4- -1.76
2026-03-30ZNTL2.150.4- -1.76
2026-03-31ZNTL2.350.4- -1.76
2026-04-01ZNTL2.580.4- -1.76
2026-04-02ZNTL2.640.4- -1.76
2026-04-06ZNTL2.6920.9- -1.70
2026-04-07ZNTL2.6820.9- -1.70
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1



20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-03-09ZNTL-4.61-17.427.62
2026-03-10ZNTL-4.61-17.427.62
2026-03-11ZNTL-4.61-17.427.62
2026-03-12ZNTL-4.61-17.427.62
2026-03-13ZNTL-4.61-17.427.62
2026-03-17ZNTL-4.61-17.417.62
2026-03-18ZNTL-4.61-17.417.62
2026-03-19ZNTL-4.61-17.417.62
2026-03-20ZNTL-4.61-17.417.62
2026-03-23ZNTL-4.61-17.417.62
2026-03-24ZNTL-4.61-17.417.62
2026-03-25ZNTL-4.61-17.418.41
2026-03-26ZNTL-4.61-17.418.41
2026-03-27ZNTL-4.61-17.418.41
2026-03-30ZNTL-4.69-17.688.57
2026-03-31ZNTL-4.69-17.688.57
2026-04-01ZNTL-4.69-17.688.57
2026-04-02ZNTL-4.69-17.688.57
2026-04-06ZNTL-4.69-17.688.57
2026-04-07ZNTL-4.69-17.688.57
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS​

-0.49

Avg. EPS Est. Current Quarter

-0.4

Avg. EPS Est. Next Quarter

-0.56

Insider Transactions

-4.69

Institutional Transactions

-17.68

Beta

1.54

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

6

Growth Score

19

Sentiment Score

96

Actual DrawDown %

96.9

Max Drawdown 5-Year %

-98.8

Target Price

5.31

P/E

Forward P/E

PEG

P/S

P/B

0.85

P/Free Cash Flow

EPS

-1.91

Average EPS Est. Cur. Y​

-1.7

EPS Next Y. (Est.)

-1.7

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.3

Return on Equity vs Sector %

-90.9

Return on Equity vs Industry %

-74.3

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.13

EBIT Estimation

◆ ZNTL Healthcare
$2.67
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
12/20
Pullback
15/25
Volume
11/15
Valuation
10/20
TP/AR
1/10
Options
8/10
RSI
54.2
Range 1M
59.4%
Sup Dist
1.5%
🚀
Momentum Growth
Ride accelerating trends
N/A
26 /100
WEAK
Momentum
5/25
Growth
11/30
Estimates
0/20
Inst/Vol
4/15
Options
6/10
EPS Yr
-7.3%
EPS NY
20.5%
52W%
57.5%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +98.9% upside
Quality
3/30
Valuation
16/30
Growth
10/25
Stability
7/10
LT Trend
3/5
Upside
+98.9%
Quality
6
Click a card to see score breakdown Full Analysis →
Zentalis Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 106
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States. The company develops azenosertib, which is in a Phase 3 clinical trial for the treatment of ovarian cancer and other tumor types. It also develops ZN-c3-001, a phase 1 study that evaluated azenosertib monotherapy in solid tumors; and MAMMOTH (ZN-c3-006) is a Phase 1/2 clinical trial of azenosertib in patients with PARP-inhibitor resistant ovarian cancer. It has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC. Zentalis Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
ZNTL

Latest News

—
Caricamento notizie per ZNTL…
stock quote shares ZNTL – Zentalis Pharmaceuticals, Inc. Stock Price stock today
news today ZNTL – Zentalis Pharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ZNTL – Zentalis Pharmaceuticals, Inc. yahoo finance google finance
stock history ZNTL – Zentalis Pharmaceuticals, Inc. invest stock market
stock prices ZNTL premarket after hours
ticker ZNTL fair value insiders trading